ViroPharma (VPHM) says it expects 2012 sales to be above Street estimates, now expecting net...

|By:, SA News Editor

ViroPharma (VPHM) says it expects 2012 sales to be above Street estimates, now expecting net product sales of $600M - $660M. The analyst consensus is for total revenue of $593M. Shares +4.8% AH.